Keywords: array, gets, 3m, ph, ii, milestone, astrazeneca
Array gets $3M Ph II milestone from AstraZeneca
Article | 25 September 2006
Colorado, USA-headquartered Array BioPharma says that it received a $3.0 million payment from Anglo-Swedish drug major AstraZeneca for achieving a Phase ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
